278549
Well-visit planner 2.0: A 2012 REACH challenge runner-up shares lessons on translation into practice
Monday, November 4, 2013
: 9:10 AM - 9:30 AM
Christina Bethell, PhD, MBA, MPH
,
Department of Pediatrics, School of Medicine, The Child and Adolescent Health Measurement Initiative, Oregon Health & Science University, Portland, OR
Scott Stumbo, MA
,
Child and Adolescent Health Measurement Initiative, Oregon Health & Science University, Portland, OR
Richard LeDonne
,
Child and Adolescent Health Measurement Initiative, Oregon Health & Science University, Portland, OR
Lewis Notestine, MA
,
Child and Adolescent Health Measurement Initiative, Oregon Health & Science University, Portland, OR
Judy Shaw, EdD, MPH, RN
,
University of Vermont, College of Medicine, Vermont Child Health Improvement Program, Burlington, VT
Edward Schor, MD
,
Lucile Packard Foundation for Children's Health, Palo Alto, CA
The Well-Visit Planner (WVP) was developed under an R40 grant from the Maternal and Child Health Bureau of the Health Resources and Services Administration and was recognized in the 2012 Relevant Evidence to Advance Care and Health (REACH) Challenge. It is one of few existing IT driven, patient engagement tools featuring pre-well-child visit planning and integration of patient-reported data into the electronic health record prior to visits. Parents or guardians of young children ages 4 months to 3 years and pediatric practices across the nation were included in the study. A systematic assessment of requirements and opportunities led to continued development and dissemination of the timely WVP. The current study has explored potential collaborations, alternative funding mechanisms, various business models and continued simultaneous development and dissemination of IT driven, patient-centered quality improvement methods like the WVP. Online tools require real world resources to maintain, improve, and disseminate. In this process we have learned that taking a funded research tool to the next step of development work requires tenacity, collaboration and determination and is not sustainable unless new models to support research translation emerge. A plan for continuation and dissemination of research work is critical for planning to implement any research product that is developed via a traditional research funding mechanism. The availability of publicly accessible, online tools for pre-visit planning and integrating patient information into the electronic medical record has profound promise and implications for quality improvement in the delivery of well-child care.
Learning Areas:
Communication and informatics
Implementation of health education strategies, interventions and programs
Other professions or practice related to public health
Social and behavioral sciences
Learning Objectives:
Identify requirements and challenges associated with translating the Well-Visit Planner (WVP) into practice in today’s health care and research funding environment.
Describe unique characteristics of WVP and the challenges that are posed by these unique characteristics (integration with Electronic Health Records, etc)
Discuss strategies to address challenges, based on study experiences and leveraging lessons from other IT-program development.
Keywords: Challenges and Opportunities, Screening
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am Director of The Child and Adolescent Health Measurement Initiative (CAHMI) and Data Resource Center for Child and Adolescent Health, where our mission is to advance a patient-centered health care system. I serve as principle investigator for the collaborative development, validation and implementation of health and health care quality tools. Additional expertise in consumer and provider engagement and IT driven methods to measure and improve health care quality within the pediatric office setting.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.